Salute e Benessere
Pediatric Vascular Access Market worth US$833.1 million by 2030 with 7.4% CAGR | MarketsandMarkets™
the Pediatric Vascular Access market is segmented into catheters, implantable ports, port needles, catheter securement and stabilization, catheter caps & closures, vascular closure devices, IV connectors, syringes and needles, infusion pumps, IV sets & accessories, intraosseous infusion devices, anesthesia injection devices, guidance devices, and others. In 2024, the guidance devices segment accounted for the second-largest market share of the Pediatric Vascular Access market. Growth in this market segment can be attributed to the critical role in ensuring precise and safe vascular access for high-risk newborns. As neonatal care becomes increasingly reliant on precision medicine, guidance devices will remain a cornerstone of vascular interventions, solidifying their position as a key driver of innovation and growth in this specialized market.
the pediatric vascular access market is divided into four segments based on application: drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing.
The fluid and nutrition administration segment is expected to grow at the second-highest CAGR during the forecast period. This expansion is due to the escalating need for specialized vascular solutions to deliver essential fluids, electrolytes, and parenteral nutrition to high-risk neonates, particularly preterm infants. As the global prevalence of prematurity rises, accounting for approximately 15 million births annually, the demand for advanced vascular devices tailored to fragile neonatal vasculature continues to surge.
, the pediatric vascular access market is segmented into five major regional segments, namely, North America , Europe , Asia Pacific , Latin America , and the Middle East & Africa . North America accounted for the largest market share in the pediatric vascular access market in 2024. The confluence of advanced healthcare infrastructure, clinical demand, and regulatory frameworks. The region's leadership stems from its high prevalence of preterm births, which drives significant demand for specialized vascular devices such as umbilical catheters, infusion pumps, and real-time monitoring systems. Neonatal intensive care units (NICUs) in North America are equipped with state-of-the-art facilities that rely heavily on these devices to manage complex conditions such as respiratory distress syndrome, congenital anomalies, and sepsis. Regulatory support, including the FDA's Pediatric Medical Device Safety and Improvement Act, accelerates approvals for neonate-specific innovations, while comprehensive insurance coverage and Medicare/Medicaid reimbursements ensure widespread adoption.
Some of the prominent players operating in the market include Becton Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE ( Germany ), AngioDynamics, Inc. (US), Terumo Corporation ( Japan ), Nipro Medical Corporation ( Japan ), and Medtronic Plc ( Ireland ), among others.
BD is a global leader in medical technology, operating in over 50 countries with core business segments in diagnostics, medication delivery, and vascular access solutions. Its product portfolio includes syringes, infusion systems, and catheters, serving hospitals, clinics, and research institutions worldwide. BD maintains manufacturing facilities in the US, Ireland , and Brazil .
Teleflex Incorporated is a multinational medical device company specializing in vascular access, critical care, and surgical tools, with well-known brands such as Arrow and LMA. Operating globally, it serves hospitals and clinics through a network of manufacturing sites, though exact locations are unspecified in the provided sources.
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/pediatric-vascular-access-market-worth-us833-1-million-by-2030-with-7-4-cagr--marketsandmarkets-302625343.html